Pharming Group Nv Stock Analysis

Pharming Stock Analysis Notes

The book value of the company was at this time reported as 0.44. The company recorded a loss per share of 0.27. Pharming Group NV had not issued any dividends in recent years. Pharming Group N.V., a biopharmaceutical company, develops and commercialize protein replacement therapies and precision medicines for the treatment of rare diseases and unmet medical needs in the United States, Europe, and internationally. Pharming Group N.V. is headquartered in Leiden, the Netherlands. Pharming Group operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 277 people. To find out more about Pharming Group NV contact MD MBA at 31 71 524 7400 or learn more at https://www.pharming.com.

Pharming Group NV Investment Alerts

Pharming Group NV Upcoming and Recent Events

Pharming Largest EPS Surprises

View All Earnings Estimates

Pharming Group Environmental, Social, and Governance (ESG) Scores

Pharming Stock Institutional Investors

Note, although Pharming Group's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Pharming Market Capitalization

The company currently falls under 'Small-Cap' category with a current market capitalization of 518.15 M.

Pharming Profitablity

The company has Profit Margin (PM) of (0.06) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of 0.05 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.05.

Management Efficiency

Pharming Group NV has return on total asset (ROA) of (0.0138) % which means that it has lost $0.0138 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.0818) %, meaning that it created substantial loss on money invested by shareholders. Pharming Group's management efficiency ratios could be used to measure how well Pharming Group manages its routine affairs as well as how well it operates its assets and liabilities. As of 12/04/2024, Return On Tangible Assets is likely to drop to -0.03. In addition to that, Return On Capital Employed is likely to drop to -0.01. At this time, Pharming Group's Total Assets are relatively stable compared to the past year. As of 12/04/2024, Non Current Assets Total is likely to grow to about 153.8 M, while Other Current Assets are likely to drop slightly above 3.4 M.

Technical Drivers

As of the 4th of December, Pharming Group holds the Risk Adjusted Performance of 0.0083, semi deviation of 3.1, and Coefficient Of Variation of 96867.96. Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Pharming Group, as well as the relationship between them. Please check Pharming Group NV standard deviation, as well as the relationship between the maximum drawdown and expected short fall to decide if Pharming Group NV is priced some-what accurately, providing market reflects its current price of 7.47 per share. Given that Pharming Group has jensen alpha of 0.0458, we recommend you to check out Pharming Group NV's recent market performance to make sure the company can sustain itself at a future point.

Pharming Group NV Price Movement Analysis

Pharming Group NV Insider Trading Activities

Pharming Group Outstanding Bonds

Pharming Group Predictive Daily Indicators

Pharming Group Corporate Filings

Pharming Group Forecast Models

Pharming Group's time-series forecasting models are one of many Pharming Group's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Pharming Group's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Pharming Group prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Pharming shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Pharming Group. By using and applying Pharming Stock analysis, traders can create a robust methodology for identifying Pharming entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Pharming analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Pharming analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Pharming Group NV stock analysis indicators help investors evaluate how Pharming Group stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Pharming Group shares will generate the highest return on investment. By understating and applying Pharming Group stock analysis, traders can identify Pharming Group position entry and exit signals to maximize returns.

When running Pharming Group's price analysis, check to measure Pharming Group's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pharming Group is operating at the current time. Most of Pharming Group's value examination focuses on studying past and present price action to predict the probability of Pharming Group's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pharming Group's price. Additionally, you may evaluate how the addition of Pharming Group to your portfolios can decrease your overall portfolio volatility.